Homocysteine is the only plasma thiol associated with carotid artery remodeling

被引:22
作者
Demuth, K
Drunat, S
Girerd, X
Moatti, N
Paul, JL
Safar, M
Boutouyrie, P
机构
[1] UFR Pharm, Hop Europeen Georges Pompidou, Lab Biochim Cardio Vasc, F-75015 Paris 11, France
[2] UFR Pharm, Lab Biochim Appl, F-75015 Paris, France
[3] Hop Broussais, Serv Med Interne, F-75674 Paris, France
[4] Hop Europeen Georges Pompidou, Serv Pharmacol, Paris, France
关键词
homocysteine; cysteine; glutathione; carotid artery; atherosclerosis;
D O I
10.1016/S0021-9150(02)00205-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several authors have reported that moderate hyperhomocysteinemia is related to asymptomatic carotid arterial wall remodeling, but few data are available on other thiol compounds with potential vascular toxicity. We, therefore, investigated the relationships between major plasma thiol compounds (homocysteine, cysteine and glutathione) and the structural phenotype of the common carotid artery in a cohort of 123 subjects with no evidence of cardiovascular disease. Fasting levels of thiol compounds were measured by high-performance liquid chromatography, and arterial geometry was evaluated using high-resolution echotracking devices. In univariate regression analysis, plasma homocysteine and plasma cysteine concentrations were positively associated with carotid artery internal diameter (P = 0.0001 and 0.002, respectively) and intima media thickness (P = 0.003 and 0.004), but the plasma glutathione concentration was not. In multivariate analysis, plasma homocysteine was independently and positively associated with carotid artery internal diameter (P < 0.005) and intima media thickness (P < 0.05), but plasma cysteine was not. These data suggest that homocysteine is the only plasma thiol compound that may be considered as a risk factor for preclinical cardiovascular disease. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 49 条
[1]   CARDIOVASCULAR-DISEASE RISK PROFILES [J].
ANDERSON, KM ;
ODELL, PM ;
WILSON, PWF ;
KANNEL, WB .
AMERICAN HEART JOURNAL, 1991, 121 (01) :293-298
[2]  
Andersson A, 1999, CLIN CHEM, V45, P1084
[3]   Redox status of plasma homocysteine and other plasma thiols in stroke patients [J].
Andersson, A ;
Hultberg, B ;
Lindgren, A .
ATHEROSCLEROSIS, 2000, 151 (02) :535-539
[4]  
ANDERSSON A, 1995, CLIN CHEM, V41, P361
[5]   ARTERIAL ALTERATIONS WITH AGING AND HIGH BLOOD-PRESSURE - A NONINVASIVE STUDY OF CAROTID AND FEMORAL ARTERIES [J].
BENETOS, A ;
LAURENT, S ;
HOEKS, AP ;
BOUTOUYRIE, PH ;
SAFAR, ME .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (01) :90-97
[6]   Influence of homocysteine on matrix metalloproteinase-2:: Activation and activity [J].
Bescond, A ;
Augier, T ;
Chareyre, C ;
Garçon, D ;
Hornebeck, W ;
Charpiot, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (02) :498-503
[7]   Association between local pulse pressure, mean blood pressure, and large-artery remodeling [J].
Boutouyrie, P ;
Bussy, C ;
Lacolley, P ;
Girerd, X ;
Laloux, B ;
Laurent, S .
CIRCULATION, 1999, 100 (13) :1387-1393
[8]   SERUM-LP(A) AS A DISCRIMINANT MARKER OF EARLY ATHEROSCLEROTIC PLAQUE AT 3 EXTRACORONARY SITES IN HYPERCHOLESTEROLEMIC MEN [J].
CAMBILLAU, M ;
SIMON, A ;
AMAR, J ;
GIRAL, P ;
ATGER, V ;
SEGOND, P ;
LEVENSON, J ;
MERLI, I ;
MEGNIEN, JL ;
PLAINFOSSE, MC ;
MOATTI, N .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (11) :1346-1352
[9]   Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia - An effect reversible with vitamin C therapy [J].
Chambers, JC ;
McGregor, A ;
Jean-Marie, J ;
Obeid, OA ;
Kooner, JS .
CIRCULATION, 1999, 99 (09) :1156-1160
[10]   Homocysteine decreases endothelin-1 production by cultured human endothelial cells [J].
Demuth, K ;
Atger, V ;
Borderie, D ;
Benoit, MO ;
Sauvaget, D ;
Lotersztajn, S ;
Moatti, N .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (02) :367-376